Antibodies to Zic4 in paraneoplastic neurologic disorders and small-cell lung cancer
- 9 March 2004
- journal article
- Published by Wolters Kluwer Health in Neurology
- Vol. 62 (5) , 778-782
Abstract
Objective: To determine whether serum Zic4 antibodies associate with paraneoplastic neurologic disorders (PND) and small-cell lung cancer (SCLC), and the association of these antibodies with other onconeuronal immunities associated with SCLC. Design/Methods: The authors studied 498 patients (215 with PND and 283 without PND or without cancer). The presence of antibodies was tested with immunoblots of Zic4, HuD, and CRMP5 proteins. The tumor expression of these proteins was determined by immunohistochemistry. Results: Zic4 antibodies were identified in 61 patients. Ninety-two percent of patients with Zic4 antibodies had SCLC; detection of these antibodies segregated with the presence of PND (p = 0.031). Intrathecal synthesis of Zic4 antibodies was demonstrated in 5/7 patients with PND. None of 175 control patients without PND or cancer had Zic4 antibodies. Because of the robust association between Zic autoimmunity and SCLC, all patients were tested for other SCLC-related antibodies; concurrent Zic4, Hu, or CRMP5 antibodies occurred in the serum or CSF of 27% of SCLC patients with PND. Patients with isolated Zic4 antibodies were more likely to develop predominant cerebellar dysfunction than patients with several immunities (p < 0.001). Tumors of patients with and without onconeuronal antibodies coexpressed Zic, Hu, and CRMP5 proteins, indicating that the tumor expression of these antigens is necessary, but not sufficient, for immunologic activation. Conclusions: In patients with neurologic symptoms of unknown cause detection of Zic4 antibodies predicts a neoplasm, usually a SCLC, and suggests that the neurologic disorder is paraneoplastic. Detection of Zic4 antibodies often associates with anti-Hu or CRMP5 antibodies. Patients with isolated Zic4 antibodies are more likely to develop cerebellar dysfunction than those with concurrent immunities.Keywords
This publication has 22 references indexed in Scilit:
- P/Q type calcium-channel antibodies in paraneoplastic cerebellar degeneration with lung cancerNeurology, 2002
- Zic1 Promotes the Expansion of Dorsal Neural Progenitors in Spinal Cord by Inhibiting Neuronal DifferentiationDevelopmental Biology, 2002
- Zic2Controls Cerebellar Development in Cooperation withZic1Journal of Neuroscience, 2002
- Cytotoxic T cell activity against the peptide, AYRARALEL, from Yo protein of patients with the HLA A24 or B27 supertype and paraneoplastic cerebellar degenerationJournal of the Neurological Sciences, 2001
- [Joubert's syndrome: report of 12 cases].2001
- Behavioral Abnormalities of Zic1 and Zic2 Mutant Mice: Implications as Models for Human Neurological DisordersBehavior Genetics, 2001
- CRMP-5 neuronal autoantibody: Marker of lung cancer and thymoma-related autoimmunityAnnals of Neurology, 2001
- Serological identification of embryonic neural proteins as highly immunogenic tumor antigens in small cell lung cancerProceedings of the National Academy of Sciences, 2000
- Zic1 regulates the patterning of vertebral arches in cooperation with Gli3Mechanisms of Development, 1999
- HLA A24 in paraneoplastic cerebellar degeneration with anti-Yo antibodyNeurology, 1996